0NLY Stock Chart & Stats
€35.38
-€0.22(-1.79%)
At close: 4:00 PM EST
€35.38
-€0.22(-1.79%)
Day’s Range― - ―
52-Week Range€9.42 - €47.00
Previous CloseN/A
Volume96.00
Average Volume (3M)2.96K
Market Cap
€1.84B
Enterprise Value€2.14B
Total Cash (Recent Filing)€76.75M
Total Debt (Recent Filing)€227.57M
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Sep 24, 2026EPS Estimate
0.33Next Dividend Ex-DateN/A
Dividend Yield1.01%
Share Statistics
EPS (TTM)-1.18
Shares Outstanding64,008,484
10 Day Avg. Volume3,083
30 Day Avg. Volume2,956
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.04
Price to Sales (P/S)0.49
P/FCF Ratio-6.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€39.00Price Target Upside10.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.89
Revenue Forecast (FY)€2.01B
Bulls Say, Bears Say
Bulls Say
Production Ramp-up & ScaleSustained volume growth and multiple plant ramp‑ups increase fixed‑cost absorption and operational leverage. Higher, diversified production across ethanol, biodiesel and biomethane supports revenue durability, strengthens market position and improves export optionality over the medium term.
Improving Cash Generation & DeleveragingMaterial improvement in operating cash flow and positive free cash flow after nine months, together with a meaningful net‑debt reduction, enhances financial flexibility. A stronger balance sheet supports capex funding, reduces refinancing risk and enables strategic investments over coming quarters.
Structural Regulatory TailwindsClear regulatory tightening in the EU (RED III) and expanded U.S. RVO increase mandated blending and remove double counting, structurally lifting demand for compliant biofuels. That regulatory backdrop supports sustained volume demand and improves long‑term revenue visibility for core products.
Bears Say
Thin, Volatile ProfitabilityMargins are currently very thin and the company is loss‑making on a TTM basis, reflecting high earnings volatility. Persistent low gross margins and negative ROE constrain self‑funding ability and make sustainable profitability dependent on durable margin improvement or sustained regulatory/pricing support.
Inconsistent Cash ConversionRecent cash recovery is encouraging, but historical swings and prior periods of negative free cash flow show unreliable conversion of earnings to cash. This volatility can impede consistent capex funding, weaken buffer against commodity swings, and raise refinancing or liquidity risk over cycles.
Operational Reliability & Seasonality RisksBiological/fermentation disruptions and marked seasonal idling reduce utilization and introduce recurring volume volatility. Such reliability and seasonality issues can depress margins, complicate supply contracts, and make earnings and cash flows less predictable across planning horizons.
0NLY FAQ
What was verbio Vereinigte BioEnergie AG’s price range in the past 12 months?
verbio Vereinigte BioEnergie AG lowest share price was €9.41 and its highest was €47.00 in the past 12 months.
What is verbio Vereinigte BioEnergie AG’s market cap?
verbio Vereinigte BioEnergie AG’s market cap is €1.84B.
When is verbio Vereinigte BioEnergie AG’s upcoming earnings report date?
verbio Vereinigte BioEnergie AG’s upcoming earnings report date is Sep 24, 2026 which is in 52 days.
How were verbio Vereinigte BioEnergie AG’s earnings last quarter?
verbio Vereinigte BioEnergie AG released its earnings results on May 13, 2026. The company reported €0.36 earnings per share for the quarter, beating the consensus estimate of €0.33 by €0.03.
Is verbio Vereinigte BioEnergie AG overvalued?
According to Wall Street analysts verbio Vereinigte BioEnergie AG’s price is currently Undervalued.
Does verbio Vereinigte BioEnergie AG pay dividends?
verbio Vereinigte BioEnergie AG pays a Annually dividend of €0.2 which represents an annual dividend yield of 1.01%. See more information on verbio Vereinigte BioEnergie AG dividends here
What is verbio Vereinigte BioEnergie AG’s EPS estimate?
verbio Vereinigte BioEnergie AG’s EPS estimate is 0.33.
How many shares outstanding does verbio Vereinigte BioEnergie AG have?
verbio Vereinigte BioEnergie AG has 64,008,484 shares outstanding.
What happened to verbio Vereinigte BioEnergie AG’s price movement after its last earnings report?
verbio Vereinigte BioEnergie AG reported an EPS of €0.36 in its last earnings report, beating expectations of €0.33. Following the earnings report the stock price went up 16.757%.
Which hedge fund is a major shareholder of verbio Vereinigte BioEnergie AG?
Currently, no hedge funds are holding shares in GB:0NLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
verbio Vereinigte BioEnergie Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€39.00 (10.23% Upside)
€39.00 (10.23% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.12%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.54%
Trailing 12-Months
Company Description
verbio Vereinigte BioEnergie AG
VERBIO Vereinigte BioEnergie AG operates as a prominent producer and supplier of sustainable biofuels throughout Germany and the broader European market. The firm's diverse portfolio features products such as biodiesel, bioethanol, biomethane, biosterol, bioglycerin, and nutrient-rich liquid fertilizers. These offerings are distributed to a wide array of clients, including major oil companies, independent fuel stations, transportation firms, public utility providers, and corporate vehicle fleets. Established in 2006, the company maintains its primary operational base in Leipzig, Germany.
0NLY Stock 12 Month Forecast
Average Price Target
€39.00
▲(10.23% Upside)